Objectives: This study aimed to describe a novel double-sheath vacuum suction minimally invasive percutaneous nephrolithotomy (mini-PCNL) to overcome the deficiencies of the conventional procedure. Patients and Methods: Between March 2019 and December 2019, 65 patients (37 males and 28 females) with a mean age of 41 years (range 23–69) underwent mini-PCNL with double-sheath vacuum suction. It consisted of an F20 Y-shaped sheath as an outer sheath and an F16 Y-shaped sheath as an inner sheath, in which the inner sheath was longer than the outer sheath. The oblique arm of the outer sheath and the inner sheath was connected to the perfusion inflow and the vacuum suction, respectively. A 550-μm holmium-YAG laser was introduced for stone fragmentation through the working channel of the mini-nephroscope, which was no longer connected to the perfusion fluid. Results: All procedures were successful. Mean operation time was 50.2 min (range 39–83). Mean hemoglobin decrease was 5.2 g/L (range 1.0–15.5), and no patient needed a blood transfusion. One patient (1.5%) with low fever (<38°C) at day 1 had returned to normal at day 2 without administration of antibiotics. There were no Clavien grade 2–4 complications. Mean postoperative hospital stay was 2.4 days (range 2–6). The initial stone-free rate of PCNL was 81.53% (53 of 65 patients). One month after surgery, the final stone-free rate increased to 90.77% (59/65 patients). Conclusions: The double-sheath vacuum suction mini-PCNL is a safe and effective modality for large renal stones, which might increase the efficiency of stone extraction with low intrapelvic pressure.

1.
Ghani
KR
,
Andonian
S
,
Bultitude
M
,
Desai
M
,
Giusti
G
,
Okhunov
Z
,
Percutaneous nephrolithotomy: update, trends, and future directions
.
Eur Urol
.
2016
;
70
(
2
):
382
96
. .
2.
Seitz
C
,
Desai
M
,
Häcker
A
,
Hakenberg
OW
,
Liatsikos
E
,
Nagele
U
,
Incidence, prevention, and management of complications following percutaneous nephrolitholapaxy
.
Eur Urol
.
2012
;
61
(
1
):
146
58
. .
3.
Kalkanli
A
,
Cilesiz
NC
,
Fikri
O
,
Ozkan
A
,
Gezmis
CT
,
Aydin
M
,
Impact of anterior kidney calyx involvement of complex stones on outcomes for patients undergoing percutaneous nephrolithotomy
.
Urol Int
.
2020
;
104
(
5–6
):
459
64
. .
4.
Ruhayel
Y
,
Tepeler
A
,
Dabestani
S
,
MacLennan
S
,
Petřík
A
,
Sarica
K
,
Tract sizes in miniaturized percutaneous nephrolithotomy: a systematic review from the European Association of Urology Urolithiasis Guidelines Panel
.
Eur Urol
.
2017
;
72
(
2
):
220
35
. .
5.
Yamaguchi
A
,
Skolarikos
A
,
Buchholz
NP
,
Chomón
GB
,
Grasso
M
,
Saba
P
,
Operating times and bleeding complications in percutaneous nephrolithotomy: a comparison of tract dilation methods in 5,537 patients in the Clinical Research Office of the Endourological Society Percutaneous Nephrolithotomy Global Study
.
J Endourol
.
2011
;
25
(
6
):
933
9
. .
6.
Abdelhafez
MF
,
Bedke
J
,
Amend
B
,
ElGanainy
E
,
Aboulella
H
,
Elakkad
M
,
Minimally invasive percutaneous nephrolitholapaxy (PCNL) as an effective and safe procedure for large renal stones
.
BJU int
.
2012
;
110
:
E1022
6
. .
7.
Lahme
S
,
Bichler
KH
,
Strohmaier
WL
,
Götz
T
.
Minimally invasive PCNL in patients with renal pelvic and calyceal stones
.
Eur Urol
.
2001
;
40
(
6
):
619
24
. .
8.
Cheng
F
,
Yu
W
,
Zhang
X
,
Yang
S
,
Xia
Y
,
Ruan
Y
.
Minimally invasive tract in percutaneous nephrolithotomy for renal stones
.
J Endourol
.
2010
;
24
(
10
):
1579
82
. .
9.
Gu
Z
,
Yang
Y
,
Ding
R
,
Wang
M
,
Pu
J
,
Chen
J
.
Comparison of retrograde intrarenal surgery and micro-percutaneous nephrolithotomy for kidney stones: a meta-analysis
.
Urol Int
.
2021
;
105
(
1–2
):
64
70
. .
10.
Wu
C
,
Hua
LX
,
Zhang
JZ
,
Zhou
XR
,
Zhong
W
,
Ni
HD
.
Comparison of renal pelvic pressure and postoperative fever incidence between standard- and mini-tract percutaneous nephrolithotomy
.
Kaohsiung J Med Sci
.
2017
;
33
(
1
):
36
43
. .
11.
Zhu
W
,
Liu
Y
,
Liu
L
,
Lei
M
,
Yuan
J
,
Wan
SP
,
Minimally invasive versus standard percutaneous nephrolithotomy: a meta-analysis
.
Urolithiasis
.
2015
;
43
(
6
):
563
70
. .
12.
Giusti
G
,
Piccinelli
A
,
Taverna
G
,
Benetti
A
,
Pasini
L
,
Corinti
M
,
Miniperc? No, thank you!
Eur Urol
.
2007
;
51
(
3
):
810
5
. .
13.
Zanetti
SP
,
Lievore
E
,
Fontana
M
,
Turetti
M
,
Gallioli
A
,
Longo
F
,
Vacuum-assisted mini-percutaneous nephrolithotomy: a new perspective in fragments clearance and intrarenal pressure control
.
World J Urol
.
2021
;
39
(
6
):
1717
23
.
14.
Lievore
E
,
Boeri
L
,
Zanetti
SP
,
Fulgheri
I
,
Fontana
M
,
Turetti
M
,
Clinical comparison of mini-percutaneous nephrolithotomy with vacuum cleaner effect or with a vacuum-assisted access sheath: a single center experience
.
J Endourol
.
2021
;
35
(
5
):
601
8
.
15.
Lai
D
,
Chen
M
,
Sheng
M
,
Liu
Y
,
Xu
G
,
He
Y
,
Use of a novel vacuum-assisted access sheath in minimally invasive percutaneous nephrolithotomy: a Feasibility Study
.
J Endourol
.
2020
;
34
(
3
):
339
44
. .
16.
Xu
Y
,
Wu
Z
,
Yu
J
,
Wang
S
,
Li
F
,
Chen
J
,
Doppler ultrasound-guided percutaneous nephrolithotomy with two-step tract dilation for management of complex renal stones
.
Urology
.
2012
;
79
(
6
):
1247
51
. .
17.
Desoky
E
,
Abd Elwahab
KM
,
El-Babouly
IM
,
Seleem
MM
.
Outcomes of flank-free modified supine percutaneous nephrolithotomy based on BMI
.
Urol Int
.
2021
;
105
(
1–2
):
77
82
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.